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Methods: Published literature from standard electronic data- 
bases concerned with treatments for osteoarthritis was reviewed. 
Focus group discussions were held with primary care physicians, 
rheumatologists and orthopaedic surgeons to explore their views 
about barriers to utilization. In-depth interviews were undertaken 
with individuals with severe hip/knee disease and low levels of 
service utilization selected from a community prevalence survey 
(Somerset and Avon Survey of Health) to explore why they had 
not sought help. Focus groups and interviews were audio- 
taped and transcribed. Analysis was according to the method of 
constant comparison. 
Results: Evidence of inequality in the provision of TJR was found 
in the literature, with wide variations in surgical rates nationally 
and internationally. Focus group discussions and literature identi- 
fied three potential barriers to appropriate utilization: people with 
joint disease not presenting to primary care physicians, primary 
care physicians not referring people to specialists, and surgeons 
refusing to operate on particular groups (e.g. young, obese). 
Recurring themes in interviews to explain why people did not 
seek health care included perceptions that they were too old or 
unwell for T JR, a view that joint problems were a normal part of 
aging, not wishing to undergo surgery, poor T JR outcomes in 
friends/relatives, and unwillingness to initiate reconsideration 
forreferral/surgery after previous refusal. 
Conclusions: There is the potential to develop strategies that 
might reduce inequality and unmet need, including referral and 
review guidelines for primary care physicians. It is al o clear that 
there is a need for further research to establish appropriate indi- 
cations for the timing of T JR that incorporate patient preferences 
and clinical factors. 
PB31 
PRIORITIES FOR TOTAL KNEE REPLACEMENT 
IN OSTEOARTHRITIS: THE PATIENTS' PERSPECTIVE 
G.M. Woolhead, J.L. Donovan, J.A. Chard, P.A. Dieppe 
MRC Health Services Research Collaboration, 
University of Bristol, UK 
Aim: To explore patients' views on who with OA should have 
priority for total knee replacement (TKR), and to compare their 
views with published criteria. 
Methods: In depth, semi-structured interviews were conducted 
on 25 patients with osteoarthritis (OA) on the waiting list for TKR 
in the UK. The interviews were tape-recorded, transcribed and 
analysed for themes. In addition, a literature search on the 
criteria for joint surgery and its prioritization in OA was under- 
taken. 
Results: All participants were willing to comment on waiting 
times and prioritization for TKR. Two major themes emerged -- 
what they thought should happen and what they thought did 
happen. Patients thought that priority for surgery should be 
based on the length and degree of suffering, pain severity, degree 
of immobility, payment of National Insurance, paid employment, 
caring for dependents and other personal circumstances. In con- 
trast they thought what actually happened depended on age and 
weight, excessive complaining and financial factors (such as 
access to private practice). Many felt that they had been unfairly 
discriminated against on the basis of age (both too young and 
too old) or obesity. The literature review found seven articles on 
criteria/prioritization forTKR, all of which were consensus based 
rather than evidence based, and none of which included the 
patients' perspective. 
Conclusions: Participants agreed with professionals that pain 
and disability should be key criteria on which to prioritize people 
for a TKR. However, they also argued for a fair and open decision- 
making process that included additional factors specific to 
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individual patient's circumstances. Criteria to aid prioritization for 
joint surgery in OA need to accommodate the views of patients as 
well as professionals. 
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BODY WEIGHT CHARACTERISTICS OF PATIENTS 
EXPERIENCING ASEPTIC LOOSENING, PERIPROSTHETIC 
FRACTURES, AND INFECTIONS AFTER TOTAL HIP 
ARTHROPLASTIES 
R. Marks 
JP Allegrante Hospital for Special Surgery, New York, NY, USA 
Aim: The aim of this study was to assess the relationship 
between selected post-surgical outcomes following total hip 
arthroplasty and the body weight characteristics of hip 
osteoarthritis patients. 
Methods: The body mass indices and percentage of ideal body 
weights relative to height of patients undergoing total hip arthro- 
plasty were assessed. The subjects were males and females 
drawn from a sample of 1000 hip osteoarthritis patients between 
the ages of 30-89 years of age who were hospitalized for pur- 
poses of hip replacement surgery or for complications related to 
prior prosthetic surgery of the hip. 
Results: Approximately 18% had experienced complications 
related to prior surgeries, or to current surgeries. High body mass 
indices and percent ideal weights differentiated those with asep- 
tic loosening, periprosthetic fractures, those with no complica- 
tions and those with infected hips (p<0.007). Conversely, those 
experiencing loosening were more likely to be underweight, 
rather than overweight (p < 0.05). 
Conclusions: A reasonable proportion of patients with hip 
osteoarthritis who undergo hip arthroplasty surgery may exper- 
ience various forms of postsurgical complications, despite the 
excellent outcomes experienced by the majority of patients. Hip 
osteoarthritis patients undergoing hip replacement surgery may 
be at heightened risk for post-surgical complications if they are 
either underweight, or they are obese. It is possible that patient 
outcomes after hip replacement surgery, may be improved by 
presurgical interventions which promote optimal dietary practices 
and the attainment of more optimal body weights relative to 
height, where these are clearly subnormal. 
PB33 
AUTOLOGOUS IN VITRO CARTILAGE. ENGINEERING, 
CHARACTERIZATION, APPLICATION 
U. Anderer, J. Libera 
co.don® Research Center, Teltow, Germany 
Aim: Our challenge in tissue engineering is the autologous in vitro 
generation of human cartilage for therapeutical pplication and in 
vitro testing. 
Methods: We established a 3-dimensional chondrocyte culture 
system without he addition of exogenous growth factors or scaf- 
folds. The expression of cartilage specific proteins like collagen 
type II, S-100 and glucosaminoglycans were analyzed on frozen 
sections of in vitro engineered cartilage-like tissue using immuno- 
histological and histological (HE-, Safranin-O staining) methods. 
Results: Spheroids of autologous cultured human chondrocytes 
generated a cartilage-like tissue similar to native hyaline cartilage. 
The expression of cartilage specific proteins and matrix compo- 
nents is increasing with extended time in culture. Adding fetal calf 
serum or antibiotics to culture medium resulted in an inhibition 
of the generation or even the destruction of in vitro engineered 
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cartilage-like tissue. The autologous engineered cartilage 
spheroids demonstrate a rapid adhesion and integration on/in 
human osteoarthritic artilage. 
Conclusions: Our approach allows for the first time the autoge- 
nous in vitro engineering of cartilage tissue that is particularly 
suitable for the regeneration of cartilage tissue in osteoarthritis as 
well as an in vitro pharmacological test system to analyze patho- 
genesis and therapeutics in osteoarthritis. 
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REGULATION OF HUMAN TYPE II COLLAGEN (COL2A1) 
EXPRESSION BY TRANSFORMING GROWTH FACTOR-b1 IN 
RABBIT ARTICULAR CHONDROCYTES 
• C Chedjichristos, C Ghayor, J-F Herrouin, J-P Pujol, P Galera 
Laboratory of Connective Tissue Biochemist~ Faculty of 
Medicine, 14032 CAEN Cedex, France 
Aim: TGF-~I effect on collagen type II expression in cultured 
chondrocytes depends on whether the cells are confluency- 
arrested or in a proliferating state. The aim of this work was to 
determine the sequence of the promoter and the transcription 
factors which are responsible for the TGF~I -induced inhibition of 
COL2A1 expression in proliferating cells. 
Methods: Rabbit articular chondrocytes (RAC) were used in pri- 
mary cultures, at about 80% of confluency. Semi-quantitative RT- 
PCR was used to determine steady-state levels of collagen type 
II. Constructs containing deletions in the promoter and/or first 
intron regions of COL2A1, fused to the luciferase reporter, were 
transfected in RAC, with or without 10% fetal calf serum. Dnase 
I footprint and gel retardation analysis were also performed. A 
vector containing the cDNA of a hybrid TGF-~I receptor (T~RII/I), 
acting as a dominant negative, has been used to verify the 
specificity of effects. 
Results: TGF-~I inhibited COL2AI gene expression via a region 
of 63 bp upstream the transcription start site. When RAC were 
cotransfected with the TBRII/I vector, the transcriptional ctiviy of 
all the COL2A1 constructs was increased, in the presence or 
absence of serum. Dnase I footprint and gel retardation analysis 
of the 63 bp showed that TGF-131-induced inhibition on COL2A1 
expression involves a multimeric omplex in which Spl and Sp3 
play a major role. 
Conclusions: Despite that TGF-131 is generally considered as a 
potent stimulant of matrix synthesis in most tissues, it exerts an 
inhibition on type II collagen expression by proliferating chondro- 
cytes, through a 63 bp sequence of the promoter which binds the 
transcription factors Spl and Sp3. This mechanism may play 
some role in the early phase of OA, when chondrocytes start 
dividing. It may participate to the reduction of collagen type II, 
a process associated with production of non specific type I 
collagen, reflecting the phenotype alteration of these cells. 
PB35 
GLUCOSAMINE HCL AND CHONDROITIN SULFATE INHIBIT 
THE CATABOLIC RESPONSE OF ARTICULAR CARITLAGE 
EXPLANTS CULTURED WITH LIPOPOLYSACCHARIDE 
M. W. Orth, T. L. Peters, J. N. Hawkins 
Department of Animal Science, Michigan State University 
East Lansing, MI, USA 
Aim: The aim of this research was to determine at what concen- 
trations glucosamine (GLN) and chondroitin sulfite (CS) would 
inhibit the cytokine-induced catabolic response in articular 
cartilage explants. 
Methods: Articular cartilage was obtained from carpal joints of 
either steers or horses. Cartilage discs (3.5 ram) were biopsied 
and three discs -were cultured per well of a 24-well culture plate. 
After 2 days of equilibration, explants were incubated with 10 
~.g/ml of lipopolysaccharide (LPS) in the presence of varying con- 
centrations of GLN (FCHG49TM) *, CS ('I'RH122TM) * or both. 
Control treatments included explants with no LPS, and LPS with- 
out GLN or CS. Media were collected daily and analyzed for nitric 
oxide (NO) and keratan sulfate (equine only). Cartilage extracts 
were analyzed for gelatinolytic activity using gel zymography. 
Activity was quantitated using scanning densitometry. Extracts 
from equine cartilage were also analyzed for MMP-13. 
Results: GLN as low as 1 mg/ml decreased NO production in 
LPS-stimulated explants. In 3 of 4 experiments the addition of 
either 0.25 or 0.50 mg/ml CS did not further decrease NO pro- 
duction. In equine cartilage, 1 mg/ml of GLN decreased MMP-13 
concentrations with no benefit from the addition of CS. Keratan 
sulfate in media (indicator of proteoglycan degradation) was max- 
imally decreased in the presence of GLN and CS. Gelatinolytic 
activity was suppressed predominantly by CS. 
Conclusions: Overall, the most consistent combination for pre- 
venting the catabolic response in the explants was 1 mg/ml GLN 
and 0.25 mg/ml CS. GLN was effective at inhibiting NO and 
MMP-I 3 production, both of which are activated via the NFk-~ 
pathway; whereas CS inhibited proteolytic activity. Thus, the two 
appear to complement one another in preventing the catabolic 
response in LPS-stimulated cartilage explants. 
*Trademarks for Nutramax Laboratories, NC., Edgewood, MD 
PB36 
GLYCERYL TRINITRATE INCREASES SUBCHONDRAL BONE 
THICKNESS AND DENSITY IN AN OVINE MENISCECTOMY 
MODEL OF OSTEOARTHRITIS 
MA Cake, RA Read, S-Y Hwa*, P Ghosh* 
Division of Veterinary and Biomedical Sciences, 
Murdoch University, Perth, Australia; 
*Institute of Bone and Joint Research, Royal North Shore 
Hospital, Sydney, Australia 
Aim: To examine the effect of glyceryl trinitrate (GTN), a nitric 
oxide (NO) donor compound, on the concurrent progression of 
subchondral bone changes in an aged ovine model of osteo- 
arthritis (OA). 
Methods: Bilateral ateral meniscectomy was performed on 12 
seven-year-old Merino ewes to induce OA. Six were treated with 
GTN twice per week, applied topically as 2% ointment (0.7 
mg/kg) (OA+GTN). Six other sheep were used as non-operated 
controls (NOC). After sacrifice at 6 months, the subchondral bone 
(SCB) density (BMD) of the lateral and medial femoral condyles 
(LFC, MFC) and tibial plateaus (LTP, MTP) was assessed by 
DEXA. Histological sections of the central weight-bearing region 
of each region were analyzed using image analysis software to 
measure the thickness of the SCB in the inner, middle, and outer 
zones of each region. 
Results: OA SCB thickness and BMD increased in the lateral 
compartment, and decreased in the medial compartment. 
OA+GTN displayed significantly greater SCB thickness relative to 
OA in the middle (in-contact) zone of the LFC (1.721 vs 1.271 mm, 
p = 0.024; NOC = 0.904) and the outer zone of the MFC (0.652 vs 
0.484 mm, p = 0.049; NOC= O.665). SCB density was greater in 
OA+GTN than in OA in the LFC (1.158 vs t.057 g m/cm 2, p = 
0.036; NOC = 0.934), LTP (1.031 vs 0.923 gm/cm.Z, p = 0.018; 
NOC = 0.830) and MTP (0.862 vs 0.772 gm/cm 2,  p = 0.014; 
NOC = 0.932). 
